BB BIOTECH AG 13D and 13G filings for Molecular Templates, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 4:13 pm Purchase |
2022-12-31 | 13G | Molecular Templates, Inc. MTEM |
BB BIOTECH AG | 746,134 19.900% |
26,667 (+3.71%) |
Filing |
| 2022-02-11 4:49 pm Purchase |
2021-12-31 | 13G | Molecular Templates, Inc. MTEM |
BB BIOTECH AG | 719,467 19.200% |
83,292 (+13.09%) |
Filing |
| 2021-04-26 1:11 pm Purchase |
2021-04-07 | 13G | Molecular Templates, Inc. MTEM |
BB BIOTECH AG | 636,175 17.000% |
210,819 (+49.56%) |
Filing |
| 2021-02-12 5:07 pm Purchase |
2020-12-31 | 13G | Molecular Templates, Inc. MTEM |
BB BIOTECH AG | 425,355 12.800% |
76,689 (+21.99%) |
Filing |
| 2020-11-03 5:33 pm Purchase |
2020-10-26 | 13G | Molecular Templates, Inc. MTEM |
BB BIOTECH AG | 348,666 10.500% |
204,590 (+142.00%) |
Filing |